Biocon Limited (BSE: 532523, NSE: BIOCON), a global biopharmaceutical innovator, has announced plans to fully
Biocon Biologics Ltd (BBL), a global biosimilars manufacturer and subsidiary of Biocon Ltd., has reached
Biocon Biologics Ltd (BBL), a global biopharmaceutical company and subsidiary of Biocon Ltd has received
Biocon Limited, a leading biopharmaceutical company, has announced an exclusive licensing and supply agreement with
Pharma major Biocon Ltd. reported a substantial decline in its consolidated net profit for the
Biocon Ltd, a leading biopharmaceutical company, has entered into a semi-exclusive distribution and supply agreement
Biocon Ltd, a leading biopharmaceutical company, has entered into a semi-exclusive distribution and supply agreement
